More Aggressive 2nd BC as a Result of Tamoxifen Use for DCIS
I've been reading through articles, such as the one above, and am rethinking the use of Tamoxifen. I'm wondering if anyone opted against the Tamoxifen because of the risk of a newer, harder to treat breast cancer that could develop. Have any of you discussed this with your oncologist. If so, what were his/her thoughts?
Comments
-
I opted out because I didn't want the other side effects.... My MO approved my decision and said the risks out weighed the benefits for me. I've not heard about this issue in the article.
-
Do you have a link for the scientific article? In the newspaper article, it just says "breast cancer patients," without any mention of DCIS?
It also says that the scientists who conducted this study concluded that it DID prevent a second cancer and that there were very few of those estrogen-negative cancer recurrences. So I'm pretty sure my MO would recommend that I continue taking Tamoxifen. Based on what I read in that article, I wouldn't even bring it up with him at my next visit.
Everybody has a different risk/benefit ratio for each treatment. In my case, I have very little risk but I get an appreciable benefit because I still may have a 10% chance of a recurrence, even after surgery and radiation tx. And we are at greater risk for another primary, I think, once we've had DCIS. I don't know what your personal numbers are, Aster.
I hope Beesie chimes in with her stats and good sense advice for you. -
I didn't get offered it as they don't test for er/pr in the UK for pure DCIS.
-
Natters,
Here is the link I think you are asking for: http://cancerres.aacrjournals.org/content/69/17/6865.short
My MO prescribed the Tamoxifen, but she doesn't seem adamant about me taking it. My risk for bc in opposite breast is 10-14% (I think). With Tamoxifen, it's half that. I'm 43 and having a difficult time with fatigue. When I consider the fatigue and the possibility of a different type of cancer that is more difficult to treat, I'm tempted to stop the Tamoxifen. But it's all so confusing. I don't want to make the wrong call on this.
-
Rads made me tired, but the Tamox is fine. I guess everyone has different side effects but the main one I get is night sweats and an unpredictable period. I'm only 43, too. All my doctors seem to think that is fairly young & that it means that we still have a lot of time in which to develop a recurrence or new cancer in the other breast. So they are telling me that even though it was just DCIS,it was a red flag, and I should be aggressive and hit it with everything. Tamox is nothing compared to MX and chemo, right? But if your MO isn't pushing it, then maybe she has her reasons...
-
PS thank you for the link to that article
-
Something else to keep in mind about Tamoxifen. If you are 43 now, your breast cancer risk spans the rest of our life, which hopefully goes on for another 40 to 50 years. For most women, their highest risk years for BC are when they are in their late 50s, 60s and 70s. 5 years of Tamoxifen reduces BC risk by about 45% but it doesn't keep working for 40 years.... the studies I've seen suggest that you get the full benefit for about 10 years and a declining benefit for another 5 years or so. That's not a reason to not take Tamoxifen, but it means that if you want to continue to reduce your BC risk after the benefits from Tamoxifen start to decline, you need to move on to another drug, likely an AI. It also means that if your 'lifetime' risk of breast cancer is 20%, Tamoxifen will not reduce your risk to 11%. Your lifetime risk is spread over the rest of your life; Tamoxifen will only provide a benefit against the portion of that risk that occurs over the next 10 - 15 years.
I was diagnosed at 49 and had a single MX. My oncologist actually recommended against Tamoxifen for me at that time, saying that if I were to take it, it might make sense to wait until I was in my higher risk years. At the time, he estimated my remaining lifetime risk to be about 22% (about double that of the average 49 year old). My risk over the next 15 years, however, was less than 8%. So Tamoxifen's benefit for me, assuming a full 45% reduction in my risk for 15 years, would have been about 3.5%. It would have taken my lifetime risk from 22% down to 18.5%. I'm now 56 and my lifetime risk is down to about 18% (lifetime risk goes down every year simply because there are fewer years left in our lifetimes). I realize that I'm now getting to the years where I would get the greatest benefit from Tamoxifen but after not taking it for all these years, I'm hesitant to start. But I have to admit that I do mull the idea around in my head.
-
Thanks for the info, Ladies.
Beesie, I had forgotten about how the risk is a "life-time" risk. It's difficult to remember all these things.
-
Hi Aster
Thanks for the article, but I also don't see anywhere that they mention DCIS in it? Do we know if this applies to Invasive as well as non-invasive (DCIS) BC?
Here's what it reads which to me implies it's related to "invasive" BC:
"We conducted a population-based nested case-control study including 367 women diagnosed with both first primary estrogen receptor (ER)–positive invasive breast cancer and second primary contralateral breast cancer and 728 matched control women diagnosed only with a first breast cancer."
http://cancerres.aacrjournals.org/content/69/17/6865.short
NSJ2
-
NSJ2, the women in the study all had invasive cancer but the study was assessing the risk of development of a second cancer. What they were looking at was the type of cancer that develops as the second primary. Whether you've had DCIS or IDC, your risk of a second primary is increased - it's not any different if you had DCIS vs. IDC. So based on that, I think it's fair to assume that the results would apply equally to someone with DCIS.
If you are taking Tamoxifen after a diagnosis of BC - whether your first diagnosis was DCIS or invasive - part of the benefit from Tamox. is a reduction in the risk that you will develop a new primary breast cancer, a diagnosis completely unrelated to your original diagnosis. A new BC can develop in either the same breast or in the contralateral breast, however this study appears to have only looked at women who developed a new primary in the contralateral breast (probably because it's difficult to know if a BC that develops in the original breast is a recurrence or a new primary). What the study concluded is that while Tamox. is effective at reducing the overall risk of developing a new primary BC, if one does develop, there's a somewhat higher chance that this second cancer will be ER-.
-
Thanks Beesie.
Well that kinda blows. One of the things Tamox is supposed to help prevent is a new primary in the contralateral breast. But if it does occur, this study implies it may be ER neg.
-
But if I understood this correctly, it does prevent new primaries? Women who took the drug were less likely than other women to get a new primary?
It actually makes sense to me that the few women who did get a new primary did NOT get a ER+ cancer, since Tamox supposedly prevents them. So that leaves the women who were going to get a ER- cancer anyway, and Tamox had nothing to do with it, one way or another.
The title of this thread suggests that Tamox causes ER- cancers, which I think is misleading. The authors of the paper concluded that Tamox prevents new cancers overall. -
Yes, Tamox does significantly reduce the risk of a new primary. And the majority of new primaries that develop are still ER+, but compared to women who didn't take Tamoxifen, a higher percentage are ER-.
I recall seeing the actual %s that are ER+ versus ER- in some report on this study. I'll see if I can dig it up.
-
Okay, I think I got this. I found the tables from the study. I'm a bit confused by them but I think I figured it out. So here's how it works out (I think):
Those who took Tamoxifen had approx. a 40% overall reduction in contralateral breast cancer compared to those who didn't take Tamoxifen.
Comparing those who didn't take Tamox. to those who did, the contralateral BCs in the non-Tamox. group were 92% ER+ and 7.0% ER-. The contralateral BCs of the Tamoxifen group were 71% ER+ and 27% ER-. So there's the 4 fold increase in ER- breast cancers.
The numbers in the study are difficult to interpret so let me translate it to easier-to-understand numbers. Let's say we have two groups of 100 women who've all had an ER+ breast cancer; Group A doesn't takes Tamoxifen while Group B does.
. No Tamox. Tamox.
# of women who don't develop a contralateral BC: Group A: 80 Group B: 88
# of cases of contralateral breast cancer: Group A: 20 Group B: 12
# of cases of ER+ contralateral BC: Group A: 18 Group B: 9
# of cases of ER- contralateral BC: Group A: 2 Group B: 3
My example isn't precise, but it's close enough; it's basically what the study is saying. The overall number of contralateral BCs is down in the Tamoxifen group but the % that are ER- is higher.
-
I recently post a thread called "Tamoxifen & Breast Cancer, an informative, must read book" I don't know how to link the post so you can search. If you want to understand Tamoxifen and how it works/interact/interfere with breast cancer, you may want to check out the book, Tamoxifen & Breast Cancer, by Michael W. DeGregorio and Valerie J. Wiebe. The book was written by a Researcher in CA. The book was given to me, and helped guide my decision. It is NOT an anti-Tamoxifen book, it describes the drug, it short/long terms SE, in language that lay person can understand.
-
It's funny how the docs almost always give you tamoxifen (or A.I.) regardless....my oncology report said that Tamoxifen would be of modest benefit but because I have a 2% risk per year of stroke from lone atrial fibrillation, I decided not to take it. I read the Er- business as well, but as with any drug, there are no free lunches and it becomes a matter of risk and benefits, as it should be. Same with radiation that has now been implicated in creating cancer stem cells....but that doesn't mean women should stop radiation that has shown clear benefits. DCIS features should guide decisions. High grade DCIS with casting appearance is suggestive of an aggressive cancer that may even hide IDC so many options should be examined here. Not all DCIS is created equal.
-
I just had right breast mx for dcis. Since my tissues we free from any invasive cancer and my sentinel nodes were also clear, surgeon said ' see you in a year' but suggested even though its not necessary that I meet with the (cant remember his official doctor type) oncology doc to establish a relationship???
As a result of a head injury from an auto accident in my mid/late 20s, I had a massive stroke which has left me with a deficit on my left side. I don't want to imagine EVER deliberately taking something that wasn't 200% necessary, that could cause a stroke....been there done that..nfw
As a side note, I turned 47 exactly 1 week after my mx ....
Categories
- All Categories
- 679 Advocacy and Fund-Raising
- 289 Advocacy
- 68 I've Donated to Breastcancer.org in honor of....
- Test
- 322 Walks, Runs and Fundraising Events for Breastcancer.org
- 5.6K Community Connections
- 282 Middle Age 40-60(ish) Years Old With Breast Cancer
- 53 Australians and New Zealanders Affected by Breast Cancer
- 208 Black Women or Men With Breast Cancer
- 684 Canadians Affected by Breast Cancer
- 1.5K Caring for Someone with Breast cancer
- 455 Caring for Someone with Stage IV or Mets
- 260 High Risk of Recurrence or Second Breast Cancer
- 22 International, Non-English Speakers With Breast Cancer
- 16 Latinas/Hispanics With Breast Cancer
- 189 LGBTQA+ With Breast Cancer
- 152 May Their Memory Live On
- 85 Member Matchup & Virtual Support Meetups
- 375 Members by Location
- 291 Older Than 60 Years Old With Breast Cancer
- 177 Singles With Breast Cancer
- 869 Young With Breast Cancer
- 50.4K Connecting With Others Who Have a Similar Diagnosis
- 204 Breast Cancer with Another Diagnosis or Comorbidity
- 4K DCIS (Ductal Carcinoma In Situ)
- 79 DCIS plus HER2-positive Microinvasion
- 529 Genetic Testing
- 2.2K HER2+ (Positive) Breast Cancer
- 1.5K IBC (Inflammatory Breast Cancer)
- 3.4K IDC (Invasive Ductal Carcinoma)
- 1.5K ILC (Invasive Lobular Carcinoma)
- 999 Just Diagnosed With a Recurrence or Metastasis
- 652 LCIS (Lobular Carcinoma In Situ)
- 193 Less Common Types of Breast Cancer
- 252 Male Breast Cancer
- 86 Mixed Type Breast Cancer
- 3.1K Not Diagnosed With a Recurrence or Metastases but Concerned
- 189 Palliative Therapy/Hospice Care
- 488 Second or Third Breast Cancer
- 1.2K Stage I Breast Cancer
- 313 Stage II Breast Cancer
- 3.8K Stage III Breast Cancer
- 2.5K Triple-Negative Breast Cancer
- 13.1K Day-to-Day Matters
- 132 All things COVID-19 or coronavirus
- 87 BCO Free-Cycle: Give or Trade Items Related to Breast Cancer
- 5.9K Clinical Trials, Research News, Podcasts, and Study Results
- 86 Coping with Holidays, Special Days and Anniversaries
- 828 Employment, Insurance, and Other Financial Issues
- 101 Family and Family Planning Matters
- Family Issues for Those Who Have Breast Cancer
- 26 Furry friends
- 1.8K Humor and Games
- 1.6K Mental Health: Because Cancer Doesn't Just Affect Your Breasts
- 706 Recipe Swap for Healthy Living
- 704 Recommend Your Resources
- 171 Sex & Relationship Matters
- 9 The Political Corner
- 874 Working on Your Fitness
- 4.5K Moving On & Finding Inspiration After Breast Cancer
- 394 Bonded by Breast Cancer
- 3.1K Life After Breast Cancer
- 806 Prayers and Spiritual Support
- 285 Who or What Inspires You?
- 28.7K Not Diagnosed But Concerned
- 1K Benign Breast Conditions
- 2.3K High Risk for Breast Cancer
- 18K Not Diagnosed But Worried
- 7.4K Waiting for Test Results
- 603 Site News and Announcements
- 560 Comments, Suggestions, Feature Requests
- 39 Mod Announcements, Breastcancer.org News, Blog Entries, Podcasts
- 4 Survey, Interview and Participant Requests: Need your Help!
- 61.9K Tests, Treatments & Side Effects
- 586 Alternative Medicine
- 255 Bone Health and Bone Loss
- 11.4K Breast Reconstruction
- 7.9K Chemotherapy - Before, During, and After
- 2.7K Complementary and Holistic Medicine and Treatment
- 775 Diagnosed and Waiting for Test Results
- 7.8K Hormonal Therapy - Before, During, and After
- 50 Immunotherapy - Before, During, and After
- 7.4K Just Diagnosed
- 1.4K Living Without Reconstruction After a Mastectomy
- 5.2K Lymphedema
- 3.6K Managing Side Effects of Breast Cancer and Its Treatment
- 591 Pain
- 3.9K Radiation Therapy - Before, During, and After
- 8.4K Surgery - Before, During, and After
- 109 Welcome to Breastcancer.org
- 98 Acknowledging and honoring our Community
- 11 Info & Resources for New Patients & Members From the Team